万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>胃肠肝病学

Clinical Gastroenterology and Hepatology《临床胃肠病学和肝病学》 (官网投稿)

简介
  • 期刊简称CLIN GASTROENTEROL H
  • 参考译名《临床胃肠病学和肝病学》
  • 核心类别 SCIE(2023版), 高质量科技期刊(T2), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率5.30%
  • 主要研究方向医学-GASTROENTEROLOGY & HEPATOLOGY胃肠肝病学

主要研究方向:

等待设置主要研究方向
医学-GASTROENTEROLOGY & HEPATOLOGY胃肠肝病学

Clinical Gastroenterology and Hepatology《临床胃肠病学和肝病学》(月刊). The mission of Clinical Gastroenterology and Hepatology (CGH) is to provide readers&nbs...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.cghjournal.org/

https://www.journals.elsevier.com/clinical-gastroenterology-and-hepatology

3、投稿网址:

https://www.editorialmanager.com/cgh/default.aspx

4、官网邮箱:cgh@gastro.org

5、官网电话:301-654-2055

6、期刊刊期:月刊,一年出版12期。

2022118日星期

                              

 

投稿须知【官网信息】

 

Guide for Authors

Clinical Gastroenterology and Hepatology (CGH) publishes clinical articles on all aspects of the digestive system, including the liver and pancreas. The types of articles CGH publishes include original papers, review articles, and special category manuscripts. Manuscripts must be prepared in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (http://www.icmje.org). CGH is a member of the Committee on Publication Ethics (COPE) (http://publicationethics.org/).

CGH has a total circulation of approximately 19,000—about 16,000 in the United States and 3,000 in other countries. 70% of subscribers are AGA members.

CGH is indexed in Current Contents, Excerpta Medica, MEDLINE®, Science Citation Index, and Scopus.

CGH strongly encourages the submission of papers on a breadth of clinical topics in gastroenterology and hepatology, especially randomized controlled trials, high-quality observational including epidemiological and outcomes studies, and novel case series. CGH is interested in several aspects of clinical and translational studies including treatment, prevention, screening, and diagnosis. High-quality systematic and meta-analyses are also welcome and will be highlighted in a special section. Publication priority will be determined by factors such as novelty, impact upon clinical practice, strength of the experimental design, and mechanistic insight.

ETHICAL STANDARDS

CGH strongly discourages the submission of more than one article dealing with related aspects of the same study. In almost all cases, a single study is best reported in a single paper.

The Journal editors consider research/publication misconduct to be a serious breach of ethics and will take action as necessary to address such misconduct, which includes submission or publication of information that:

Is intentionally erroneous,

Has been published elsewhere by a different author without acknowledgment (plagiarism),

Has been published elsewhere by the same author without acknowledgment (duplicate publication), or

Is subsequently published elsewhere by the same author without acknowledgment, attribution, or permission from the AGA Institute, as holder of the copyright, to reprint or adapt the material.

Each author who submits a manuscript to CGH must attest to several author statements in the manuscript management system, thereby assigning copyright of the manuscript to the AGA Institute and affirming authorship responsibility, manuscript originality, payment of color reproduction fees, IRB/Animal Care Committee approval, role of study sponsor, financial disclosures, and funding sources.

Breaches of CGH's ethical standards may result in proscribed submission for all authors of the concerned manuscript and, when appropriate, notification of the authors' institutions. All authors are fully responsible for the content of the manuscript.

The publication of abstracts is not considered duplicate publication but should be disclosed in the cover letter accompanying the manuscript submission.

CONFLICT OF INTEREST POLICY

A. Potential Conflicts of Interest

The following are examples of COI that may occur with editors, authors (including invited authors), and reviewers. Interactions considered pertinent are from the start of the research activity in a specific program until such time that a submission is anticipated to be published or one year from submission date, whichever is longer.

a. Editors: Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Examples of personal involvement with an author include former student, fellow, mentor, or relative. Examples of professional involvement include academic rivalry, being from the same institution or research group as the author, evaluating a manuscript for which they are listed as an author, or collaborating (e.g., co-authoring research article or grant) with an author. Examples of financial involvement include employment, consultancies, honoraria, stock ownership or options, expert testimony, grants/patents received, and royalties with an entity (or competing entity) discussed in the manuscript.

……

更多详情:

https://www.elsevier.com/journals/clinical-gastroenterology-and-hepatology/1542-3565/guide-for-authors


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭